Esperion Therapeutics, Inc. (ESPR)

3.005 +0.28 (+10.48%) USD  |  NASDAQ  |  Mar 09, 15:45
More

Esperion Therapeutics Preferred Stock Dividend (% of Annual Revenues)

Preferred Stock Dividend (% of Annual Revenues) Chart

View Preferred Stock Dividend (% of Annual Revenues) for ESPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock Dividend (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock Dividend (% of Annual Revenues) Range, Past 5 Years

View Preferred Stock Dividend (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock Dividend (% of Annual Revenues) Benchmarks

View Preferred Stock Dividend (% of Annual Revenues) Benchmarks
Start Trial
Harrow, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
AnaptysBio, Inc. Upgrade